NCT05027308View on ClinicalTrials.gov

A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older

PHASE3CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

September 27, 2023

Study Completion Date

September 27, 2023

Conditions
Short Bowel Syndrome
Interventions
DRUG

Teduglutide

Teduglutide 0.05 mg/kg SC injection

Trial Locations (6)

Unknown

University of Tsukuba Hospital, Tsukuba

Tohoku University Hospital, Sendai

Showa University Hospital, Shinagawa-ku

Akita University Hospital, Akita

Kyushu University Hospital, Fukuoka

Kagoshiha University Hospital, Kagoshima

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT05027308 - A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older | Biotech Hunter | Biotech Hunter